AI-generated summary
The authors describe a portable transcranial photobiomodulation system that is triggered by EEG-detected sleep, designed to stimulate removal of toxins such as soluble amyloid beta from the brains of aged BALB/c mice. The technology was used in home cages without anesthesia, and the authors present it as a basis for future preclinical and clinical work rather than reporting a demonstrated treatment effect in the abstract.
- Who or what was studied
- Aged BALB/c mice
- Limits stated in the abstract
- The abstract reports no quantitative results, controls or sample size, and the work is in mice, so clinical effectiveness is not established.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on app.jove.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Transcranial photobiomodulation, Electroencephalography. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.